PATENT CLAIM ANALYSIS

Application Number: 16178817
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-09
Patent Classification: ["514", "248000"]

Abstract:
3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4.

Claim (Index 4):
A compound according to  claim 1 , wherein\n W is selected from the group consisting of wherein each of these ring systems are optionally substituted with one or more R 3 .

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.03333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14275879', '15685588', '15526361', '16048665', '15526360']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8538231080277523
- 35 USC 102 Novelty (BERT): 0.569587442599169
- Combined Prediction Score: 0.8253995414848939
- Mean Citation Score: 427.91361400000005
- Max Citation Score: 444.39554
- Similarity Product: 441.5051122844672

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test